CORZ · Nasdaq, OTC, Nasdaq, Nasdaq · CIK 0001839341

Core Scientific, Inc./tx

Core Scientific, Inc./tx’s most recent SEC filing in our snapshot is a Form 4 filed on Oct 20, 2026. In fiscal 2025 (year ended Dec 31, 2025) it reported revenue of $319.0M and net income of -$288.6M, according to its XBRL data on EDGAR. Its EDGAR record lists 60 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2025
$319.0M
Net income, FY2025
-$288.6M
Form 4 filings on record, past 12 months
60

Company overview

Legal name (as filed)
Core Scientific, Inc./tx
Tickers
CORZ, CORZR, CORZW, CORZZ
SEC Central Index Key (CIK)
0001839341
Industry (SIC)
Finance Services (code 6199)
Business address
DOVER, DE
State or country of incorporation
DE
Fiscal year ends
December 31
SEC filer category
Large accelerated filer
Position in SEC ticker list
#1464 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from Core Scientific, Inc./tx’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.

Revenue
$544.5MFY2021$640.3MFY2022$502.4MFY2023$510.7MFY2024$319.0MFY2025
Net income
$47.3MFY2021-$2.1BFY2022-$246.5MFY2023-$1.4BFY2024-$288.6MFY2025
CORZ annual results
ItemFY2021
ended Dec 31, 2021
FY2022
ended Dec 31, 2022
FY2023
ended Dec 31, 2023
FY2024
ended Dec 31, 2024
FY2025
ended Dec 31, 2025
Revenue$544.5M$640.3M$502.4M$510.7M$319.0M
Net income$47.3M-$2.1B-$246.5M-$1.4B-$288.6M
Diluted EPS$0.20-$6.30-$0.65-$4.87-$0.88
Total assets$2.4B$807.7M$712.2M$1.5B$2.3B
Cash and equivalents$117.9M$15.9M$50.4M$836.2M$311.4M

XBRL tags used: revenue = Revenues; netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

CORZ latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
Mar 2, 202610-KAnnual report· period Dec 31, 2025Document · Index
Jul 28, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Sep 10, 20268-KRegulation FD disclosure· period Sep 10, 2026Document · Index
Mar 31, 2026DEF 14ADefinitive proxy statement· period May 12, 2026Document · Index

Recent SEC filings

The 40 newest documents filed by or about Core Scientific, Inc./tx, by form type:

CORZ recent filings
FiledFormWhat it isOriginal
Oct 20, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 16, 2026Document · Index
Oct 20, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 16, 2026Document · Index
Oct 14, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 12, 2026Document · Index
Oct 13, 2026144Notice of proposed sale of securitiesDocument · Index
Oct 7, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 5, 2026Document · Index
Oct 5, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 1, 2026Document · Index
Oct 5, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 1, 2026Document · Index
Sep 30, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 28, 2026Document · Index
Sep 23, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 21, 2026Document · Index
Sep 17, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 15, 2026Document · Index
Sep 16, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 14, 2026Document · Index
Sep 10, 20268-KRegulation FD disclosure· period Sep 10, 2026Document · Index
Sep 10, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 8, 2026Document · Index
Sep 2, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 31, 2026Document · Index
Aug 27, 20268-KMaterial agreement; New financial obligation; Regulation FD disclosure· period Aug 25, 2026Document · Index
Aug 26, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 24, 2026Document · Index
Aug 24, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 20, 2026Document · Index
Aug 20, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 18, 2026Document · Index
Aug 19, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 17, 2026Document · Index
Aug 14, 20268-KRegulation FD disclosure; Other events· period Aug 13, 2026Document · Index
Aug 14, 2026SCHEDULE 13GPassive beneficial ownership report (over 5%)Document · Index
Aug 14, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Aug 14, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Aug 12, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Aug 12, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 10, 2026Document · Index
Aug 5, 2026SCHEDULE 13GPassive beneficial ownership report (over 5%)Document · Index
Aug 5, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 3, 2026Document · Index
Aug 4, 2026SCHEDULE 13D/AActive beneficial ownership report (over 5%)Document · Index
Aug 3, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 30, 2026Document · Index
Aug 3, 20263Initial statement of beneficial ownership· period Jul 29, 2026Document · Index
Jul 31, 2026SCHEDULE 13GPassive beneficial ownership report (over 5%)Document · Index
Jul 29, 20268-KDirector or officer change; Regulation FD disclosure· period Jul 29, 2026Document · Index
Jul 29, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 27, 2026Document · Index
Jul 28, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Jul 28, 20268-KResults of operations; Regulation FD disclosure· period Jul 28, 2026Document · Index
Jul 28, 20268-KUnregistered equity sale; Regulation FD disclosure· period Jul 27, 2026Document · Index
Jul 22, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 20, 2026Document · Index
Jul 20, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 16, 2026Document · Index
Jul 20, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 16, 2026Document · Index
Jul 15, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 13, 2026Document · Index

Insider filing activity

60 Form 4 filings appear in Core Scientific, Inc./tx’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in Finance Services

All 47 companies in Finance Services· Companies headquartered in Delaware

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0001839341 and XBRL company facts. Core Scientific, Inc./tx on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.